Selected research
Industry Growth & Trends
Global Menopause Blood Test Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Menopause Blood Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Menopause Blood Test market include Thriva, MyHealthChecked, Forth, Labcorp OnDemand, Randox, Mina Health, OptimallyMe, Welzo and Quest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Menopause Blood Test market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Menopause Blood Test market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Menopause Blood Test market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Menopause Blood Test.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Menopause Blood Test market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Menopause Blood Test Market by Company
Thriva
MyHealthChecked
Forth
Labcorp OnDemand
Randox
Mina Health
OptimallyMe
Welzo
Quest
LifeCell
High Trees Clinics
Thorne HealthTech
Everlywell
ZRT Laboratory
Medichecks
Menopause Blood Test Segment by Type
Fingerstick Blood
Venous Blood
Menopause Blood Test Segment by Application
Premenopausal
Postmenopausal
Menopause Blood Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Menopause Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Blood Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Menopause Blood Test companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Premenopausal
- Postmenopausal
Companies covered
- Thriva
- MyHealthChecked
- Forth
- Labcorp OnDemand
- Randox
- Mina Health
- OptimallyMe
- Welzo
- Quest
- LifeCell
- High Trees Clinics
- Thorne HealthTech
- Everlywell
- ZRT Laboratory
- Medichecks
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Menopause Blood Test Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Menopause Blood Test Market Size by Region (2021-2032)
- 1.4.1 Global Menopause Blood Test Market Size by Region (2021-2026)
- 1.4.2 Global Menopause Blood Test Market Size by Region (2027-2032)
- 1.5 Key Regions Menopause Blood Test Market Size (2021-2032)
- 1.5.1 North America Menopause Blood Test Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Menopause Blood Test Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Menopause Blood Test Market Size Growth Rate (2021-2032)
- 1.5.4 South America Menopause Blood Test Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Menopause Blood Test Market Size Growth Rate (2021-2032)
2 Menopause Blood Test Market by Type
- 2.1 Type Introduction
- 2.1.1 Fingerstick Blood
- 2.1.2 Venous Blood
- 2.2 Global Menopause Blood Test Market Size by Type
- 2.2.1 Global Menopause Blood Test Market Size Overview by Type (2021-2032)
- 2.2.2 Global Menopause Blood Test Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Menopause Blood Test Market Size Forecasted by Type (2027-2032)
- 2.3 Global Menopause Blood Test Market Size by Regions
- 2.3.1 North America Menopause Blood Test Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Menopause Blood Test Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Menopause Blood Test Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Menopause Blood Test Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Menopause Blood Test Market Size Breakdown by Type (2021-2026)
3 Menopause Blood Test Market by Application
- 3.1 Type Introduction
- 3.1.1 Premenopausal
- 3.1.2 Postmenopausal
- 3.2 Global Menopause Blood Test Market Size by Application
- 3.2.1 Global Menopause Blood Test Market Size Overview by Application (2021-2032)
- 3.2.2 Global Menopause Blood Test Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Menopause Blood Test Market Size Forecasted by Application (2027-2032)
- 3.3 Global Menopause Blood Test Market Size by Regions
- 3.3.1 North America Menopause Blood Test Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Menopause Blood Test Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Menopause Blood Test Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Menopause Blood Test Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Menopause Blood Test Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Menopause Blood Test Industry Trends
- 4.2 Menopause Blood Test Industry Drivers
- 4.3 Menopause Blood Test Industry Opportunities and Challenges
- 4.4 Menopause Blood Test Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Menopause Blood Test Revenue (2021-2026)
- 5.2 Global Menopause Blood Test Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Menopause Blood Test Key Company Headquarters & Area Served
- 5.4 Global Menopause Blood Test Company, Product Type & Application
- 5.5 Global Menopause Blood Test Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Menopause Blood Test Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Menopause Blood Test Players Market Share by Revenue in 2025
- 5.6.3 2025 Menopause Blood Test Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thriva
- 6.1.1 Thriva Company Information
- 6.1.2 Thriva Business Overview
- 6.1.3 Thriva Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thriva Menopause Blood Test Product Portfolio
- 6.1.5 Thriva Recent Developments
- 6.2 MyHealthChecked
- 6.2.1 MyHealthChecked Company Information
- 6.2.2 MyHealthChecked Business Overview
- 6.2.3 MyHealthChecked Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 MyHealthChecked Menopause Blood Test Product Portfolio
- 6.2.5 MyHealthChecked Recent Developments
- 6.3 Forth
- 6.3.1 Forth Company Information
- 6.3.2 Forth Business Overview
- 6.3.3 Forth Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Forth Menopause Blood Test Product Portfolio
- 6.3.5 Forth Recent Developments
- 6.4 Labcorp OnDemand
- 6.4.1 Labcorp OnDemand Company Information
- 6.4.2 Labcorp OnDemand Business Overview
- 6.4.3 Labcorp OnDemand Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Labcorp OnDemand Menopause Blood Test Product Portfolio
- 6.4.5 Labcorp OnDemand Recent Developments
- 6.5 Randox
- 6.5.1 Randox Company Information
- 6.5.2 Randox Business Overview
- 6.5.3 Randox Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Randox Menopause Blood Test Product Portfolio
- 6.5.5 Randox Recent Developments
- 6.6 Mina Health
- 6.6.1 Mina Health Company Information
- 6.6.2 Mina Health Business Overview
- 6.6.3 Mina Health Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Mina Health Menopause Blood Test Product Portfolio
- 6.6.5 Mina Health Recent Developments
- 6.7 OptimallyMe
- 6.7.1 OptimallyMe Company Information
- 6.7.2 OptimallyMe Business Overview
- 6.7.3 OptimallyMe Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 OptimallyMe Menopause Blood Test Product Portfolio
- 6.7.5 OptimallyMe Recent Developments
- 6.8 Welzo
- 6.8.1 Welzo Company Information
- 6.8.2 Welzo Business Overview
- 6.8.3 Welzo Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Welzo Menopause Blood Test Product Portfolio
- 6.8.5 Welzo Recent Developments
- 6.9 Quest
- 6.9.1 Quest Company Information
- 6.9.2 Quest Business Overview
- 6.9.3 Quest Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Quest Menopause Blood Test Product Portfolio
- 6.9.5 Quest Recent Developments
- 6.10 LifeCell
- 6.10.1 LifeCell Company Information
- 6.10.2 LifeCell Business Overview
- 6.10.3 LifeCell Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 LifeCell Menopause Blood Test Product Portfolio
- 6.10.5 LifeCell Recent Developments
- 6.11 High Trees Clinics
- 6.11.1 High Trees Clinics Company Information
- 6.11.2 High Trees Clinics Business Overview
- 6.11.3 High Trees Clinics Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 High Trees Clinics Menopause Blood Test Product Portfolio
- 6.11.5 High Trees Clinics Recent Developments
- 6.12 Thorne HealthTech
- 6.12.1 Thorne HealthTech Company Information
- 6.12.2 Thorne HealthTech Business Overview
- 6.12.3 Thorne HealthTech Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Thorne HealthTech Menopause Blood Test Product Portfolio
- 6.12.5 Thorne HealthTech Recent Developments
- 6.13 Everlywell
- 6.13.1 Everlywell Company Information
- 6.13.2 Everlywell Business Overview
- 6.13.3 Everlywell Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Everlywell Menopause Blood Test Product Portfolio
- 6.13.5 Everlywell Recent Developments
- 6.14 ZRT Laboratory
- 6.14.1 ZRT Laboratory Company Information
- 6.14.2 ZRT Laboratory Business Overview
- 6.14.3 ZRT Laboratory Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 ZRT Laboratory Menopause Blood Test Product Portfolio
- 6.14.5 ZRT Laboratory Recent Developments
- 6.15 Medichecks
- 6.15.1 Medichecks Company Information
- 6.15.2 Medichecks Business Overview
- 6.15.3 Medichecks Menopause Blood Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Medichecks Menopause Blood Test Product Portfolio
- 6.15.5 Medichecks Recent Developments
7 North America
- 7.1 North America Menopause Blood Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Menopause Blood Test Market Size by Country (2021-2026)
- 7.3 North America Menopause Blood Test Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Menopause Blood Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Menopause Blood Test Market Size by Country (2021-2026)
- 8.3 Europe Menopause Blood Test Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Menopause Blood Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Menopause Blood Test Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Menopause Blood Test Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Menopause Blood Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Menopause Blood Test Market Size by Country (2021-2026)
- 10.3 South America Menopause Blood Test Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Menopause Blood Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Menopause Blood Test Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Menopause Blood Test Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst